Successful application of CytoSorb<sup>®</sup> hemadsorption in an immunocompromised teenager with collapsing glomerulopathy, acute respiratory distress syndrome, and sepsis.

KELEŞ E., Fidan K., Yenicesu I., Kalkan G.

The International journal of artificial organs, cilt.42, sa.12, ss.765-769, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 12
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1177/0391398819858174
  • Dergi Adı: The International journal of artificial organs
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.765-769
  • Anahtar Kelimeler: Cytosorb hemadsorption, immunocompromised, sepsis, therapeutic apheresis, collapsing glomerulopathy, SHORT-TERM SURVIVAL, DIRECT HEMOPERFUSION, SEPTIC SHOCK, HEMOADSORPTION, HEMODIAFILTRATION, ADSORBENT, THERAPY, COLUMN
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: CytoSorb (R) hemadsorption is an adjunctive therapy in order to reduce elevated cytokine levels of interleukin-6, interleukin-1, and tumor necrosis factor alpha. Here we present a successful administration of CytoSorb (R) hemadsorption in an immunocompromised pediatric patient with collapsing glomerulopathy, acute respiratory distress syndrome, and sepsis.